Papillary thyroid carcinoma with fibromatosis-like stroma: a report of two cases.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 12446921)

Published in Endocr Pathol on January 01, 2002

Authors

Michiko Inaba1, Shinobu Umemura, Haruhiro Satoh, Yasuko Ichikawa, Yosifumi Abe, Kiyoshi Kirokawa, Hideto Sakai, R Yoshiyuki Osamura

Author Affiliations

1: Division of Nephrology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Bohseidai, Isehara, Japan. 9jmmdoo5@is.icc.u-tokyo.ac.jp

Articles by these authors

Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor. Eur Urol (2008) 2.80

Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol (2010) 2.18

Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells. Genes Cells (2002) 1.83

A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. Nephrol Dial Transplant (2006) 1.64

Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol (2003) 1.49

A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol (2009) 1.44

Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int (2004) 1.42

Acute interstitial nephritis with polyclonal B cell infiltration and development of mantle cell lymphoma. Intern Med (2002) 1.42

Expression of constitutively activated EGFRvIII in non-small cell lung cancer. Cancer Sci (2003) 1.17

Two cases of ductal adenoma of the breast. Breast Cancer (2006) 1.14

Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis (2005) 1.11

The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway. J Biol Chem (2005) 1.09

Increased phosphorylation of Akt in triple-negative breast cancers. Cancer Sci (2007) 1.04

Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: HER2 gene amplification and p53 mutation. Int J Oncol (2003) 1.01

Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis. Gynecol Oncol (2006) 1.00

Ten cases of sebaceous carcinoma arising in nevus sebaceus. J Dermatol (2008) 1.00

Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma. Pathol Int (2009) 0.99

Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer. Lung Cancer (2004) 0.99

Immunohistochemical evaluation of hormone receptors in breast cancer: which scoring system is suitable for highly sensitive procedures? Appl Immunohistochem Mol Morphol (2004) 0.98

Pathology of pituitary tumors. Neurosurg Clin N Am (2003) 0.97

DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumors. J Clin Endocrinol Metab (2013) 0.95

Expression of human nephrin mRNA in diabetic nephropathy. Nephrol Dial Transplant (2004) 0.94

Olfactory neuroblastoma causing ectopic ACTH syndrome. Endocr J (2005) 0.94

Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character. Oncol Rep (2008) 0.93

Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry. Am J Kidney Dis (2003) 0.93

High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy. Kidney Int (2004) 0.93

Clinicopathological and molecular histochemical review of skull base metastasis from differentiated thyroid carcinoma. Acta Histochem Cytochem (2013) 0.92

HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens. BMC Cancer (2010) 0.92

Dysadherin: expression and clinical significance in thyroid carcinoma. J Clin Endocrinol Metab (2003) 0.90

Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model. J Mol Histol (2004) 0.89

Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway. J Obstet Gynaecol Res (2010) 0.88

Hypothesis for the mechanism for heat-induced antigen retrieval occurring on fresh frozen sections without formalin-fixation in immunohistochemistry. J Mol Histol (2008) 0.88

Myxoid leiomyoma of the vulva: a case report. Tokai J Exp Clin Med (2002) 0.88

X-ray microtomographic imaging of three-dimensional structure of soft tissues. Tissue Eng Part C Methods (2008) 0.88

Three-dimensional imaging of the intracellular localization of growth hormone and prolactin and their mRNA using nanocrystal (Quantum dot) and confocal laser scanning microscopy techniques. J Histochem Cytochem (2005) 0.88

Cocaine- and amphetamine-regulated transcript peptide in the rat anterior pituitary gland is localized in gonadotrophs and suppresses prolactin secretion. Endocrinology (2004) 0.88

Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays. Am J Clin Pathol (2007) 0.88

What causes discrepancies in HER2 testing for breast cancer? A Japanese ring study in conjunction with the global standard. Am J Clin Pathol (2008) 0.87

Undifferentiated spindle and giant cell carcinoma of the common bile duct. Tokai J Exp Clin Med (2003) 0.87

A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism. Mod Pathol (2002) 0.87

A family showing resistance to thyroid hormone associated with chronic thyroiditis and its clinical features: A case report. Endocr J (2006) 0.86

Tissue-specific expression of renin-angiotensin system components in IgA nephropathy. Am J Nephrol (2005) 0.86

Cytological features of the cystic fluid of pancreatic schwannoma with cystic degeneration. A case report. JOP (2008) 0.86

[Guidelines for the management of rapidly progressive glomerulonephritis]. Nihon Jinzo Gakkai Shi (2002) 0.86

Granulogenesis in non-neuroendocrine COS-7 cells induced by EGFP-tagged chromogranin A gene transfection: identical and distinct distribution of CgA and EGFP. J Histochem Cytochem (2007) 0.85

Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression. Oncol Rep (2005) 0.85

Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy. Clin Exp Nephrol (2004) 0.85

Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography. Nephrol Dial Transplant (2003) 0.85

Costimulatory molecules CD80 and CD86 in human crescentic glomerulonephritis. Am J Kidney Dis (2003) 0.84

Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocr Pathol (2002) 0.84

Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors. Oncol Rep (2002) 0.84

Antiproteinuric effect of candesartan cilexetil in Japanese subjects with type 2 diabetes and nephropathy. Diabetes Res Clin Pract (2004) 0.83

Impaired tight junction sealing and precocious involution in mammary glands of PKN1 transgenic mice. J Cell Sci (2007) 0.83

Microtomographic analysis of neuronal circuits of human brain. Cereb Cortex (2009) 0.83

Submicrometer tomographic resolution examined using a micro-fabricated test object. Micron (2009) 0.83

A new reporting form for breast cytology. Breast Cancer (2009) 0.83

Utility of immunohistochemistry in breast cancer practice. Breast Cancer (2004) 0.83

Glucose dialysate induces mitochondrial DNA damage in peritoneal mesothelial cells. Perit Dial Int (2002) 0.83

Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression. Arch Gynecol Obstet (2008) 0.83

Identification of transcriptional regulatory elements in the human somatostatin receptor sst2 promoter and regions including estrogen response element half-site for estrogen activation. J Mol Endocrinol (2008) 0.83

Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1. Arch Gynecol Obstet (2008) 0.82

Evaluation of HER2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH). Pathol Int (2010) 0.82

Gefitinib-induced lung injury successfully treated with high-dose corticosteroids. Respirology (2006) 0.82

Quantification of neutral cysteine protease bleomycin hydrolase and its localization in rat tissues. J Biochem (2006) 0.82

Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer. Pathol Res Pract (2009) 0.82

Expression of GATA-2 in human pituitary adenomas. Mod Pathol (2002) 0.82

Sevoflurane stimulates MAP kinase signal transduction through the activation of PKC alpha and betaII in fetal rat cerebral cortex cultured neuron. Acta Histochem Cytochem (2006) 0.81

Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer. Int J Oncol (2004) 0.81

Clinical significance of costimulatory molecules CD80/CD86 expression in IgA nephropathy. Kidney Int (2004) 0.81

Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma. Pathol Int (2002) 0.81

Subglottic leiomyosarcoma of the larynx; a case report. Auris Nasus Larynx (2004) 0.81

An up-to-date anti-cancer treatment strategy focusing on HIF-1alpha suppression: its application for refractory ovarian cancer. Acta Histochem Cytochem (2007) 0.81

Validity of retrospective review of medical records as a means of identifying adverse events: comparison between medical records and accident reports. J Eval Clin Pract (2008) 0.80

Three-dimensional CT and histopathological findings of airway malacia in Hunter syndrome. Tokai J Exp Clin Med (2007) 0.80

The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review. Breast Cancer (2009) 0.80

[Revised criteria for the early diagnosis of diabetic nephropathy]. Nihon Jinzo Gakkai Shi (2005) 0.79

Case of uterine cervical carcinosarcoma. J Obstet Gynaecol Res (2005) 0.79

Renal cell carcinoma arising in a long pre-existing angiomyolipoma. Pathol Int (2007) 0.79

Association of hepatocyte growth factor expression with salivary gland tumor differentiation. Pathol Int (2003) 0.79

PTTG overexpression is correlated with angiogenesis in human pituitary adenomas. Endocr Pathol (2006) 0.79

Impaired regulation of gonadotropins leads to the atrophy of the female reproductive system in klotho-deficient mice. Endocrinology (2005) 0.79

Long-term prognosis of parathyroid function for chronic dialysis patients after minimally invasive radioguided parathyroidectomy (MIRP). Nephrol Dial Transplant (2003) 0.79

Glomerular expression of connective tissue growth factor mRNA in various renal diseases. Nephrology (Carlton) (2003) 0.79

Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors. Invest New Drugs (2010) 0.78

Alteration of immunohistochemical biomarkers between pre- and post-chemotherapy: hormone receptors, HER2 and Ki-67. Breast Cancer (2011) 0.78

Analyses of the mechanism of intracellular transport and secretion of pituitary hormone, with an insight of the subcellular localization of pituitary hormone and its mRNA. Brain Tumor Pathol (2006) 0.78

Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules. Pathol Res Pract (2003) 0.78

Prognosis of parathyroid function after minimally invasive radioguided parathyroidectomy (MIRP) and percutaneous ethanol injection therapy (PEIT) for primary hyperparathyroidism. Biomed Pharmacother (2002) 0.77

Establishment of stable GH3 cell line expressing enhanced yellow fluorescein protein-growth hormone fusion protein. J Histochem Cytochem (2005) 0.77

Co-transfection of EYFP-GH and ECFP-rab3B in an experimental pituitary GH3 cell: a role of rab3B in secretion of GH through porosome. Folia Histochem Cytobiol (2008) 0.77

Phosphorylation of cAMP response element binding protein (CREB) as a marker of hypoxia in pituitary adenoma. J Neurooncol (2006) 0.77

Kinobeon A as a potent tyrosinase inhibitor from cell culture of safflower: in vitro comparisons of kinobeon A with other putative inhibitors. Planta Med (2003) 0.77

Expression and significance of c-met protein in papillary thyroid carcinoma. Tokai J Exp Clin Med (2002) 0.76